skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic Disease

Abstract

Colorectal cancer is a common malignancy that most commonly metastasizes to the liver. There has been considerable effort in developing new treatment options for these patients. One method that has been developed for the treatment of colorectal metastases to the liver is irinotecan-loaded drug-eluting bead (DEBIRI) embolization. This article reviews the current literature on DEBIRI and discusses the state of current knowledge and possible areas of future investigation.

Authors:
; ; ;  [1]
  1. University of Minnesota, Department of Radiology, Division of Interventional Radiology (United States)
Publication Date:
OSTI Identifier:
22645245
Resource Type:
Journal Article
Resource Relation:
Journal Name: Cardiovascular and Interventional Radiology; Journal Volume: 40; Journal Issue: 4; Other Information: Copyright (c) 2017 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); http://www.springer-ny.com; Country of input: International Atomic Energy Agency (IAEA)
Country of Publication:
United States
Language:
English
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; DRUGS; LIVER; METASTASES; NEOPLASMS; PATIENTS; REVIEWS; VASCULAR DISEASES

Citation Formats

Young, Shamar, E-mail: youn1862@umn.edu, D’Souza, Donna, Flanagan, Siobhan, and Golzarian, Jafar. Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic Disease. United States: N. p., 2017. Web. doi:10.1007/S00270-016-1537-5.
Young, Shamar, E-mail: youn1862@umn.edu, D’Souza, Donna, Flanagan, Siobhan, & Golzarian, Jafar. Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic Disease. United States. doi:10.1007/S00270-016-1537-5.
Young, Shamar, E-mail: youn1862@umn.edu, D’Souza, Donna, Flanagan, Siobhan, and Golzarian, Jafar. Sat . "Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic Disease". United States. doi:10.1007/S00270-016-1537-5.
@article{osti_22645245,
title = {Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic Disease},
author = {Young, Shamar, E-mail: youn1862@umn.edu and D’Souza, Donna and Flanagan, Siobhan and Golzarian, Jafar},
abstractNote = {Colorectal cancer is a common malignancy that most commonly metastasizes to the liver. There has been considerable effort in developing new treatment options for these patients. One method that has been developed for the treatment of colorectal metastases to the liver is irinotecan-loaded drug-eluting bead (DEBIRI) embolization. This article reviews the current literature on DEBIRI and discusses the state of current knowledge and possible areas of future investigation.},
doi = {10.1007/S00270-016-1537-5},
journal = {Cardiovascular and Interventional Radiology},
number = 4,
volume = 40,
place = {United States},
year = {Sat Apr 15 00:00:00 EDT 2017},
month = {Sat Apr 15 00:00:00 EDT 2017}
}